Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Disitamab vedotin's trials
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Disitamab vedotin
Ongoing
Active not recruiting
Phase 2
Open NCT06003231 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT06003231 · Trial Tracker · ComplyRx
